This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mahale, A. M. Articles by Aaronson, S. A. Search for Related Content PubMed PubMed Citation Articles by Mahale, A. M. Articles by Aaronson, S. A.

Clonal Selection in Malignant Transformation of Human Fibroblasts Transduced with Defined Cellular Oncogenes

¹ Department of Oncological Sciences, Mount Sinai School of Medicine and ² Department of Cell Biology, Memorial Sloan Kettering Cancer Center, New York, New York; and ³ Cutaneous Biology Research Center, Massachusetts General Hospital and Harvard Medical School, Charlestown, Massachusetts

Requests for reprints: Stuart A. Aaronson, Mount Sinai School of Medicine, One Gustave L. Levy Place, New York, NY 10029. Phone: 212-659-5400; Fax: 212-987-2240; E-mail: stuart.aaronson{at}mssm.edu.

Key Words: defined cellular genes • clonal tumor evolution • human cell transformation

Recent evidence has implied that disruption of a limited number of defined cellular pathways is necessary and sufficient for neoplastic conversion of a variety of normal human cell types in tissue culture. We show instead that malignancy in such models results from an iterative process of clonal selection in vitro and/or in vivo. Normal human fibroblasts underwent malignant transformation after transduction with telomerase, cyclin-dependent kinase 4, dominant-negative p53, and activated Ras or MEK. Furthermore, culture conditions favoring overgrowth resulted in clonal selection, which with added Ras or MEK oncogenes led to the emergence of tumorigenic clones. Such tumors showed variable degrees of malignancy with some even exhibiting metastasis. SV40 small t antigen (ST) has been reported to be necessary and sufficient to convert human fibroblasts with these pathway aberrations to a polyclonal tumor. However, we observed that clonal tumors emerged even with ST addition. Genomic instability was markedly increased by p53 and Rb pathway abrogation. Under the same conditions, fibroblasts with these alterations failed to induce tumors, implying that genomic instability may be necessary but not sufficient for malignant transformation. These findings indicate that the minimum number of events required for malignant transformation of human fibroblasts is greater than has been enumerated by such oncogene addition strategies and support a stochastic cancer progression model initiated by four defined cellular alterations. [Cancer Res 2008;68(5):1417–26]

This article has been cited by other articles:

				P. Mali, Z. Ye, H. H. Hommond, X. Yu, J. Lin, G. Chen, J. Zou, and L. Cheng Improved Efficiency and Pace of Generating Induced Pluripotent Stem Cells from Human Adult and Fetal Fibroblasts Stem Cells, August 1, 2008; 26(8): 1998 - 2005. [Abstract] [Full Text] [PDF]